Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.01 CAD -33.33% Market Closed
Market Cap: 636.6k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Replicel Life Sciences Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Replicel Life Sciences Inc
Operating Income Peer Comparison

Comparables:
ABCL
ARCH
IOT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Replicel Life Sciences Inc
XTSX:RP
Operating Income
-CA$1.4m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Income
-$237.2m
CAGR 3-Years
N/A
CAGR 5-Years
-212%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Operating Income
-CA$5.5m
CAGR 3-Years
11%
CAGR 5-Years
-24%
CAGR 10-Years
-33%
Innovotech Inc
XTSX:IOT
Operating Income
-CA$519.1k
CAGR 3-Years
N/A
CAGR 5-Years
-164%
CAGR 10-Years
2%

See Also

What is Replicel Life Sciences Inc's Operating Income?
Operating Income
-1.4m CAD

Based on the financial report for Sep 30, 2023, Replicel Life Sciences Inc's Operating Income amounts to -1.4m CAD.

What is Replicel Life Sciences Inc's Operating Income growth rate?
Operating Income CAGR 5Y
11%

Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for Replicel Life Sciences Inc have been 12% over the past three years , 11% over the past five years .

Back to Top